Not recruiting
Bladder transitional cell carcinoma
Not recruitingStudy of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment
Registered drugNo placebo
Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment
Registered drugNo placebo
- Disease:Bladder transitional cell carcinoma
- Substances:RO7284755BCG (BACILLUS CALMETTE-GUÉRIN), LIVE ATTENUATED, STRAIN RIVM (STRAIN 1173-P2 DERIVED)
Countries:
Denmark
Denmark- Participants:18–64 years · 65+ years
- Substances:RO7284755
